CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, announced
today that Hany Massarany, President and Chief Executive Officer, will
present at the Canaccord Genuity Medical Technologies & Diagnostics Form
to be held in New York, NY at the Westin Grand Central Hotel on
Thursday, November 17, 2016 at 1:30 p.m. Eastern Time. The presentation
will be made available at http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated,
multiplex molecular diagnostic testing systems that detect and measure
DNA and RNA targets to diagnose disease and optimize patient treatment.
Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT-8® system is designed to
support a broad range of molecular diagnostic tests with a compact,
easy-to-use workstation and self-contained, disposable test cartridges.
The eSensor detection technology is also incorporated into GenMark's
sample-to-answer system, ePlex®. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161101006967/en/
GenMark Diagnostics, Inc.
Hany Massarany, 760-448-4325
Chief Executive Officer
Source: GenMark Diagnostics, Inc.
News Provided by Acquire Media